Mutational analysis of forkhead transcriptional factor 2 (FOXL2) in Korean patients with blepharophimosis-ptosis-epicanthus inversus syndrome

Clinical Genetics

Volumn 64, Issue 6, 2003, Pages 485-490

  Cha, S C ^a   Jang, Y S ^a   Lee, J H ^a   Kim, H K ^a   Kim, S C ^a   Kim, S ^a   Baek, S H ^a   Jung, W S ^a   Kim, Jae Ryong ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

BPES; FOXL2; Korean patients; Mutation

Indexed keywords

ADENINE; AMINO ACID; CYTOSINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXL2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLEPHAROPHIMOSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPICANTHUS; EYELID DISEASE; FAMILIAL DISEASE; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE DUPLICATION; GENE SEQUENCE; GENETIC CODE; GENETIC DISORDER; GENETIC SCREENING; HUMAN; KOREA; MALE; MUTATIONAL ANALYSIS; NONSENSE MUTATION; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PTOSIS; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ADULT; BASE SEQUENCE; BLEPHAROPHIMOSIS; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; KOREA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEDIGREE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE ANALYSIS, DNA; SYNDROME; TRANSCRIPTION FACTORS;

EID: 0344740660     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-0004.2003.00162.x     Document Type: Article

References (20)

1. Owens N, Hadley RC, Kloepfer HW. Hereditary blepharophimosis, ptosis and epicanthus inversus. J Intern Coll Surg 1960: 33: 558-574.
2. Stromme P, Sandboe F. Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES). Acta Ophthalmol Scand 1996: 74: 45-47.
3. Zlotogora J, Sagi M, Cohen T. The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet 1983: 35: 1020-1027.
4. Fukushima Y, Wakui K, Nishida T et al. Blepharophimosis sequence and de novo balanced autosomal translocation [46,XY,t(3;4)(q23; p15.2)]: possible assignment of the trait to 3q23. Am J Med Genet 1991: 40: 485-487.
5. Amati P, Chomel JC, Nivelon-Chevalier A et al. A gene for blepharophimosis-ptosis-epicanthus inversus syndrome maps to chromosome 3q23. Hum Genet 1995: 96: 213-215.
6. Boccone L, Meloni A, Falchi AM et al. Blepharophimosis, ptosis, epicanthus inversus syndrome, a new case associated with de novo balanced autosomal translocation [46,XY,t(3;7)(q23;q32)]. Am J Med Genet 1994: 51: 258-259.
7. Harrar HS, Jeffery S, Patton MA. Linkage analysis in blepharophimosis-ptosis syndrome confirms localisation to 3q21-24. J Med Genet 1995: 32: 774-777.
8. Maw M, Kar B, Biswas J et al. Linkage of blepharophimosis syndrome in a large Indian pedigree to chromosome 7p. Hum Mol Genet 1996: 5: 2049-2054.
9. Dollfus H, Kumaramanickavel G, Biswas P et al. Identification of a new TWIST mutation (7p21) with variable eyelid manifestations supports locus homogeneity of BPES at 3q22. J Med Genet 2001: 38: 470-472.
10. Crisponi L, Deiana M, Loi A et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001: 27: 159-166.
11. Cocquet J, Pailhoux E, Jaubert F et al. Evolution and expression of FOXL2. J Med Genet 2002: 39: 916-921.
12. De Baere E, Dixon MJ, Small KW et al. Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum Mol Genet 2001: 10: 1591-1600.
13. De Baere E, Beysen D, Oley C et al. FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet 2003: 72: 478-487.
14. Bell R, Murday VA, Patton MA et al. Two families with blepharophimosis/ptosis/epicanthus inversus syndrome have mutations in the putative forkhead transcription factor FOXL2. Genet Test 2001: 5: 335-338.
15. Yamada T, Hayasaka S, Matsumoto M et al. Heterozygous 17-bp deletion in the forkhead transcription factor gene, FOXL2, in a Japanese family with blepharophimosis-ptosis-epicanthus inversus syndrome. J Hum Genet 2001: 46: 733-736.
16. Ramirez-Castro JL, Pineda-Trujillo N, Valencia AV et al. Mutations in FOXL2 underlying BPES (types 1 and 2) in Colombian families. Am J Med Genet 2002: 113: 47-51.
17. Kosaki K, Ogata T, Kosaki R et al. A novel mutation in the FOXL2 gene in a patient with blepharophimosis syndrome: differential role of the polyalanine tract in the development of the ovary and the eyelid. Ophthalmic Genet 2002: 23: 43-47.
18. Fokstuen S, Antonarakis SE, Blouin JL. FOXL2-mutations in blepharophimosis-ptosis-epicanthus inversus syndrome (BPES); challenges for genetic counseling in female patients. Am J Med Genet 2003: 117A: 143-146.
19. Dollfus H, Stoetzel C, Riehm S et al. Sporadic and familial blepharophimosis-ptosis-epicanthus inversus syndrome: FOXL2 mutation screen and MRI study of the superior levator eyelid muscle. Clin Genet 2003: 63: 117-120.
20. Kim JR, Kim SY, Kim MJ et al. Alterations of CDKN2 (MTS1/p16INK4A) gene in paraffin-embedded tumor tissues of human stomach, lung, cervix and liver cancers. Exp Mol Med 1998: 30: 109-114.